You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Molecular Cloning and Analysis of Two Subunits of the Human TFIID Complex: hTAFII130 and hTAFII100
Naoko Tanese, Daman Saluja, Milo F. Vassallo, Jin-Long Chen and Arie Admon
Proceedings of the National Academy of Sciences of the United States of America
Vol. 93, No. 24 (Nov. 26, 1996), pp. 13611-13616
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/40948
Page Count: 6
You can always find the topics here!Topics: Complementary DNA, Proteins, HeLa cells, Amino acids, Yeasts, Resins, Drosophila, DNA, Transcription factors, Regional identity
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Transcription factor TFIID is a multiprotein complex composed of the TATA box-binding protein (TBP) and multiple TBP-associated factors (TAFs). TFIID plays an essential role in mediating transcriptional activation by gene-specific activators. Numerous transcriptional activators have been characterized from mammalian cells; however, molecular analysis of the components of mammalian TFIID has been incomplete. Here we describe isolation of cDNAs encoding two TAF subunits of the human transcription factor TFIID. The first cDNA is predicted to encode the C-terminal 947 residues of the 130-kDa human TAF subunit, hTAFII130. The second cDNA encodes the C-terminal 801 residues of the 100-kDa subunit, hTAFII100. Recombinant TAFs expressed in human cells by transient transfections are capable of associating with the endogenous TAFs and TBP to form a TFIID complex in vivo. Protein binding experiments demonstrate that hTAFII130, like its Drosophila homolog dTAFII110, interacts with the glutamine-rich activation domains of the human transcription factor Sp1. Furthermore, hTAFII130 shows reduced binding to the Sp1 mutants with impaired ability to activate transcription, suggesting a role for hTAFII130 as a direct coactivator target for Sp1.
Proceedings of the National Academy of Sciences of the United States of America © 1996 National Academy of Sciences